HAEMONETICS CORP (HAE)
$103.80-$1.04 (-0.99%) Today
Martin D. Madaus - Director
Ellen M. Zane - Director
Lloyd Emerson Johnson - Director
Michael J. Coyle - DirectorHaemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 20,304 | |
| Tax withholding / forfeiture | 2 | 572 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
30 Form 4 filings on record, the earliest from Nov 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Martin D. Madaus - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Ellen M. Zane - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Claire Pomeroy - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Mark W. Kroll - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Lloyd Emerson Johnson - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Michael J. Coyle - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Diane M. Bryant - Director | Grant or award | Common Stock | 2,538 | - | - | |
 Robert E. Abernathy - Director | Grant or award | Common Stock | 2,538 | - | - | |
| Farris Maryanne Maunsell - Officer | Tax withholding / forfeiture | Common Stock | 259 | $71.28 | $18K | |
| Laurie A. Miller - Officer | Tax withholding / forfeiture | Common Stock | 313 | $71.28 | $22K | |
| Michelle L. Basil - Officer | Tax withholding / forfeiture | Common Stock | 2,913 | $56.29 | $164K | |
| Michelle L. Basil - Officer | Grant or award | Common Stock | 28,424 | - | - | |
 Frank Chan - Officer | Tax withholding / forfeiture | Common Stock | 546 | $56.29 | $31K | |
| Frank Chan - Officer | Grant or award | Common Stock | 27,535 | - | - | |
| James Darecca - Officer | Tax withholding / forfeiture | Common Stock | 2,505 | $56.29 | $141K | |
| James Darecca - Officer | Grant or award | Common Stock | 29,312 | - | - | |
| Farris Maryanne Maunsell - Officer | Tax withholding / forfeiture | Common Stock | 197 | $56.29 | $11K | |
| Farris Maryanne Maunsell - Officer | Grant or award | Common Stock | 2,220 | - | - | |
| Roy Galvin - Officer | Tax withholding / forfeiture | Common Stock | 879 | $56.29 | $49K | |
| Roy Galvin - Officer | Grant or award | Common Stock | 27,535 | - | - | |
| Laurie A. Miller - Officer | Tax withholding / forfeiture | Common Stock | 948 | $56.29 | $53K | |
| Laurie A. Miller - Officer | Grant or award | Common Stock | 13,323 | - | - | |
 Christopher Simon, - Officer | Tax withholding / forfeiture | Common Stock | 9,681 | $56.29 | $545K | |
| Christopher Simon, - Officer | Grant or award | Common Stock | 78,344 | - | - | |
| James Darecca - Officer | Tax withholding / forfeiture | Common Stock | 655 | $59.26 | $39K | |
| Mark W. Kroll - Director | Open-market purchase | Common Stock | 1,400 | $70.56 | $99K | |
| Roy Galvin - Officer | Tax withholding / forfeiture | Common Stock | 145 | $50.01 | $7K | |
| Laurie A. Miller - Officer | Tax withholding / forfeiture | Common Stock | 238 | $49.95 | $12K | |
| Robert E. Abernathy - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Mark W. Kroll - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Lloyd Emerson Johnson - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Diane M. Bryant - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Claire Pomeroy - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Ellen M. Zane - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Charles J. Dockendorff - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Michael J. Coyle - Director | Grant or award | Common Stock | 2,693 | - | - | |
| Roy Galvin - Officer | Tax withholding / forfeiture | Common Stock | 161 | $71.48 | $12K |
HAEMONETICS CORP (HAE) had 10 insider filings in the last 90 days, with the most recent on 2026-07-28. The full record for HAE runs to 30 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of HAE were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of HAE were filed in the last 90 days.
This page tracks HAE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add HAE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
